Article citationsMore>>

M. Terblanche, Y. Almog, R. S. Rosenson, T. S. Smith and D. G. Hackman, “Statins and Sepsis: Multiple Modifications at Multiple Levels,” Lancet Infectious Diseases, Vol. 7, No. 5, 2007, pp. 358-368.
http://dx.doi.org/10.1016/S1473-3099(07)70111-1

has been cited by the following article:

• TITLE: Statins and Sepsis Literature Review

  AUTHORS: Alicia Hernández Torres, Ana Belén Hernández Cascales, Pedro Pujante Alarcón, Alfonso López Ruiz, María Ángeles Ibáñez Gil, María Dolores Hellín Gil

  KEYWORDS: Statins; Pravastatin; Simvastatin; Sepsis; Bacteremia; Mortality

  JOURNAL NAME: Pharmacology & Pharmacy, Vol.4 No.8, November 8, 2013

  ABSTRACT: Recent data suggest that, in addition to improving dyslipidemia, statin may reduce the risk of infections and infection-related complications. The aim of this study is to make a review of the literature about the effects of statins on clinically relevant outcomes of patients admitted to the hospital and having an infection and/or sepsis, principally in terms of intensive care unit admissions and related death.